Diapharm legt de basis voor de toekomstige groei van de gezondheidzorg-industrie in Europa: Wij bieden licenties voor een groot aantal innovatieve OTC-producten en dossiers met duidelijke, qua regelgeving gewaarborgde indicaties en interessante strategische concepten.
Wij ontwikkelen nieuwe en innovatieve OTC-producten voor de Europese markt ten dele samen met onze dochtermaatschappijen red otc development. Voor geneesmiddelen staan alle vergunningsdocumenten als CTD-dossier (Common Technical Document) ter beschikking. Voor alle OTC-producten verzorgen wij indien nodig de noodzakelijke werkzaamheden op het gebied van de regelgeving.
Laat het ons weten als er volgens u een product of dossier in de lijst hieronder ontbreekt! Wij ontwikkelen individuele, exclusieve geneesmiddelen, medische producten, voedingssupplementen en cosmetica.
Capsella, 400 mg coated tablet
Eine OTC-Innovation zur Verminderung starker Menstruationsblutungen
Request a Download Link via Email 
Achillea millefolium, 250 mg film-coated tablet
Eine OTC-Indikation zur symptomatischen Behandlung leichter Krämpfe während der Menstruation (ab 12 Jahre)
Request a Download Link via Email 
Laden Sie sich hier die Gesamtübersicht aller verfügbaren Arzneimittel, Medizinprodukte, Nahrungsergänzungsmittel und Kosmetika herunter!
Request a Download Link via Email | Produkt | Dosierung | Darreichungsform | |
|---|---|---|---|
| Harpagophytum (Devil's claw root) | 600 mg | Film-coated tablet | |
| Tanacetum (Feverfew herb) | 100 mg | Capsule | |
| Tanacetum (Feverfew herb) forte | 200 mg | Film-coated tablet | |
| Produkt | Dosierung | Darreichungsform | |
|---|---|---|---|
| Achillea millefolium (Yarrow) | 250 mg | Film-coated tablet | |
| Agnus castus (Chaste tree fruit) | 4 mg | Film-coated tablet | |
| Capsella (Shepherd's purse) | 400 mg | Coated tablet | |
| Cimicifuga (Black cohosh rhizome) | 6.5 mg | Film-coated tablet | |
| Hypericum + Cimicifuga (St. John's Wort herb + Black cohosh rhizome) | 300 mg + 6.4 mg | Coated tablet | |
| Produkt | Dosierung | Darreichungsform | |
|---|---|---|---|
| Cough and Cold Soft Gelatine Capsules | Soft Gelatine Capsules | | |
| Hedera helix (Ivy leaves) | 16 mg | Thin-film | |
| Hedera helix (Ivy leaves) | 33 mg per 4 ml | Syrup | |
| Ibuprofen + Pseudoephedrine | 200 mg + 30 mg | Dissolvable granulate | |
| Ibuprofen + Pseudoephedrine (IbuSinex) | 200 mg + 30 mg | Coated tablet | |
| Pelargonium (Pelargonium root) | 20 mg | Oro-dispersible tablet (ODT) | |
| Pelargonium (Pelargonium root) | 20 mg | Film-coated tablet | |
| Pelargonium Syrup | 20 mg | Syrup | |
| Plantago (Ribwort plantain leaves) | 1.0 g per 10 ml | Syrup | |
| Plantago (Ribwort plantain leaves) | 300 mg | Effervescent tablet | |
| Sisymbrium (Hedge mustard) | 10 mg | Oromucosal tablet / lozenge | |
| Produkt | Dosierung | Darreichungsform | |
|---|---|---|---|
| Achillea millefolium (Yarrow) (Gastro) | 250 mg | Film-coated tablet | |
| Silybum (Milk thistle fruit) | 177.4 mg - 240.4 mg | Capsule | |
| Produkt | Dosierung | Darreichungsform | |
|---|---|---|---|
| Hypericum (St. John's Wort herb) | 425 mg | Coated tablet | |
| Hypericum + Valeriana (St. John's Wort herb + Valerian root) | 120 mg, 56 mg | Coated tablet | |
| Produkt | Dosierung | Darreichungsform | |
|---|---|---|---|
| Passiflora (Passionflower herb) | 425 mg | Coated tablet | |
| Passiflora + Valeriana (Passionflower herb + Valerian root) | 250 mg + 125 mg | Coated tablet | |
| Valeriana (Valerian root) | 450 mg | Coated tablet | |
| Valeriana + Passiflora + Melissa (Valerian root + Melissa leaf + Passionflower herb) | 125 mg + 112.5 mg + 80 mg | Coated tablet | |
| Produkt | Dosierung | Darreichungsform | |
|---|---|---|---|
| Betula (Birch leaves) | 107 mg + 42.4 mg | Coated tablet | |
| Urtica (Nettle root) | 460 mg | Film-coated tablet | |
| Produkt | Darreichungsform | |
|---|---|---|
| Anti Corn | Pen | |
| Callus Remover Instant | Solution | |
| NoLice | Mousse | |
| NoLice After Treatment | Shampoo | |
| NoLice Defence | Spray | |
| NoSkito repellent range | Spray, lotion, gel, etc. | |
